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Abstract
Introduction
Chronic kidney disease (CKD) has a set of clinical and laboratory abnormalities where renal
function loss is noted. The high prevalence of comorbidity of people living with CKD, its eco-
nomic impact and its prognosis have made it a public health problem, justifying the need to
implement preventive measures.
Objective
To analyse the mortality and incidence of hospital admissions for CKD.
Methods
Ecological study with a time series design using secondary microdata of deaths and hospital
admissions from patients with CKD from 1996 to 2017 in the State of Espı´rito Santo, Brazil.
Results
The average mortality rate of CKD during the studied years was 2.92 per 100,000 inhabi-
tants per year. During this period global mortality was a stationary phenomenon. In women,
the trend of mortality from 2005 on increased 7,87% per year. Between 2008 and 2017, the
average incidence hospital admissions due to CKD per year was 45.76 per 100,000 inhabi-
tants. It was observed that the overall hospital admission increased by the equivalent of
6.23% per year. More than a half of mortality and hospitalisations correspond to male
patients over 50 years of age. In terms of mortality, 32.99% corresponded to Caucasian
patients, while 35.13% of hospitalisations were mixed race.
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Conclusion
We found that age and gender are factors associated with deaths and hospitalisations for
chronic kidney disease. While hospitalisation increases 6.23% per year, global mortality
remains stationary. However, from 2005 onwards a trend towards increasing of 7.87%/
annual in mortality was observed in women.
Introduction
Chronic kidney disease (CKD) is characterised by damage to the renal structure or a functional
reduction of kidneys for a period of three or more months. It is a fast-growing epidemic, a
major public health problem worldwide and is responsible for about 850,000 deaths a year,
making it the twelfth largest cause of death [1].
This disease presents a progressive evolution and a close relationship with cardiovascular
diseases, whose coexistence is associated with greater morbidity, hospitalisation events and
mortality [2]. The damage to these patients also includes psychological disorders, job losses,
low professional performance and low quality of life [3].
In the United States the prevalence of CKD between 2012 and 2013 reached 14% and the
incidence of end stage renal disease (ESRD) was 353 cases per million/year. In Brazil, an inci-
dence of 170 cases of ESRD per million / year and a prevalence of around 6% for CKD was
reported for the same period [4].
The increase in the prevalence of CKD in the last decade is largely due to an aging popula-
tion and an increase in life expectancy, accompanied by an increase in main risk factors of
CKD, namely hypertension and diabetes [5].
Renal replacement therapy (RRT) is the only way to maintain life for advanced stages of the
disease, the need for RRT is growing annually at a rate of 7%. The options for RRT are haemo-
dialysis, peritoneal dialysis and renal transplantation. However, more than two-thirds of
patients with CKD die without starting RRT, from those who start dialysis only one-third sur-
vive more than five years [6,7].
Kidney transplantation (living donor or deceased) confers a better likelihood of survival
and improve quality of life together with lower financial costs, as compared to the other thera-
pies. However, this is performed in only 7% of Brazilian patients [3].
According to the Brazilian Society of Nephrology (SBN) [8] in 2012, more than 100,000
people received dialysis. This is about three times more frequent in patients over 65 years old
and generates huge expenses due to highly complex surgery, examinations, materials and
equipment, hospitals, among others [9].
It has become a concern that the majority of patients diagnosed with CKD requiring RRT
are coming from developing countries, this disease is closely related to a lack of investment in
health, poverty, lack of basic sanitation, malnutrition, a high prevalence of infectious diseases
and great difficulty in access to health prevention, promotion and treatment programs [10].
It has been observed an unequal access to care for patients in the early stages of CKD. Dur-
ing this period the disease is silent but risk factors for the progression of the disease need to be
searched, identified and combated. Some factors may affect patient outcomes such as the
shortage of specialist nephrologists or lack of clinician training in primary health care, as rec-
ommended by the Unified health System (SUS) [11].
Measures such as early diagnosis of renal disease, immediate referral to specialists and treat-
ment its complications and comorbidities have been advocated as a better strategy for patient
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care. Such measures may reduce the short and long term mortality rate, the length of hospital
stay, financial cost and consequently, improve patient´s quality of life [12].
On the other hand, there are few reliable and available registries of patients with CKD. Such
resources could underpin better planning of specific actions, providing a focus to understand
CKD and support the more efficient use of financial resources in Brazil [13].
In front of this scenery we wondered how are shown the mortality rate and incidence of
hospitalisations for CKD in the state of Espı´rito Santo from 1996 to 2017?
It is believed that knowing the profile of patients, the incidence of hospitalisation and mor-
tality rate of CKD in the state can contribute towards better disease management. It could also
allow health care professionals to implement best health care practices with better administra-
tion of financial resources.
This study aims to analyse the mortality rate and hospital admission incidence for chronic
kidney disease in the State of Espı´rito Santo from 1996 to 2017.
Methods
This is an ecological research conducted in 2018 with time series design using secondary
micro data of hospital deaths and hospitalisations for CKD patients, residents in the state of
Espı´rito Santo [14]. This study involves only the description and analysis of population
obtained from the general population census; deaths collected from the Mortality Information
System (SIM). All these sources of information are in the public domain and freely accessible.
No individual identification information of patients was obtained for this study.
Sources of information systems
SIM receives, processes, gives consistency and validity to the basic cause of death recorded in
the Death Certificate and provides information on more than 96% of deaths in Brazil [15].
The Hospital Information System of the Unified Health System (SIH / SUS) registers more
than 85% of admissions from public and private hospitals registered in the SUS and includes
92.3% of health units in Brazil [16]. Data were collected according date of hospitalisation and
from patients residing in the State of Espirito Santo.
Size of Brazilian population was obtained from the last census, carried out in 2010, and pro-
jections for the remaining years were carried out by the Brazilian Institute of Geography and
Statistics website (IBGE - www.ibge.gov.br). The Espı´rito Santo State is located in the South-
east of the country, with a population of 3,514,952 people. It has a Human Development Index
(HDI) of 0.740. In 2010 had 2,931,472 residents in urban areas and 583,480 in rural areas. [17].
Mortality rates and incidence of hospital admission and hospital mortality by CKD were
analysed for the State of Espı´rito Santo and by Health Region (or by IBGE micro-region),
crude and standardised by age group using the world standard population of World Health
Organization between 2000–2025 for total population and stratified according to age group
(i.e. 1 to 19 years, 20 to 49 years and 50 years or more), gender (male and female) and subtypes
of Chronic Renal Insufficiency [18].
Place and period of research
Microdata were collected by place of residence, hospital admissions and place of death. The
unit of analysis was the state of Espı´rito Santo, with a population of 3.5 million [17]. Death
data corresponded to the period between January 1, 1996 and December 31, 2016 (since 1996,
death declarations were coded using ICD-10), while data from hospital admissions corre-
sponded to the period between January 1, 2008 and December 31, 2017 (from 2008 a new set
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of procedures, drugs, orthotics and prosthetics and special materials were implemented by the
SUS).
Variables and data extraction
We considered all deaths and hospital admissions over one year, in public and/or private
accredited hospitals of SUS during 1996–2016 and 2008–2017, respectively. Chronic Kidney
Disease (CKD) was defined according to the 10th revision of the International Classification of
Diseases (ICD-10), through the code used in N18.
Microdata were extracted from the file transfer service provided by the Department of
Informatics of SUS (DATASUS) (www.datasus.gov.br). It is worth mentioning that these sys-
tems support the analyses of the health situation, evidence-based decision-making and public
policy development in the country. Through this public official database we collected informa-
tion on deaths and hospitalisations for chronic kidney disease (CKD).
The study of mortality may help to understand the epidemiology of CKD. Data obtained
from information systems maintained by the Ministry of Health are reliable. Particularly in the
state of Espı´rito Santo (Southeast Brazil), information systems have good quality and com-
pleteness [18], enabling their use as a feasible tool for assessing CKD.
The TABNET and TABWIN software were used to analyse the data. These tools were devel-
oped by DATASUS for quick tabbing on DBF files. Data were collected by two independent
researchers to identify discrepancies.
Statistical analysis
Mortality rates, incidence of hospitalisation, stratified by age groups, year by year (1996–2017),
were expressed per 100,000 inhabitants, grossly and standardised using direct method, follow-
ing the world standard population of WHO in the year 2000–2025 [18].
For trend analyses, we followed the methodological guidelines presented by Antunes and
Cardoso [19]. We applied Prais-Winsten regression model to the population rates of deaths
and hospitalisations to build time series, which allows the first-order autocorrelation to be cor-
rected in the analysis of time series organised values. The following values were estimated:
slope (β), its probability (p) and coefficient of determination (r2), considering a 95% signifi-
cance level.
This procedure made it possible to classify trends in mortality and hospitalisation as
increasing, decreasing or stationary, in addition to quantifying the annual increase degree of
the rate. Stata 14.0 software was used for statistics calculations (CollegeStation, TX, 2013).
Results
Table 1 illustrates frequencies of deaths, mortality rate (1996–2016) and the incidence and fre-
quency of hospitalisations (2008–2017) in the state of Espı´rito Santo. The time trend analysis
of such as variables is shown in Table 2.
The State of Espı´rito Santo, between 1996 and 2016 reached the number of 1,936 deaths
from CKD, on average 96.8 deaths per year, which corresponds to the average mortality rate of
2.92 per 100,000 inhabitants per year. It was identified that during this period, global mortality
was a stationary phenomenon, as can be observed in Fig 1.
When stratified by gender, the phenomenon remained stationary when evaluated over the
20-year period, although it suggests an increase between 2011 and 2014. (Fig 2). However,
when evaluating the trend of mortality for years> 2005, it was observed an increase of 7.87%
per year for women.
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In the age groups of 1 to 19 and 50 or more years, mortality remained stationary; however,
for the age group of 20 to 49 years, a decrease of 4.41% per year was noticed.
Regarding admissions, between 2008 and 2017, the average incidence per year was 45.76
per 100,000 inhabitants, which corresponds to a frequency of 14,622 cases, which is equivalent
to the average of 1,624.6 hospitalisations per year.
Table 1. Mortality rates and incidence of hospital admission for CKD in Espı´rito Santo State, Brazil, 1996 to 2017.
STATE OF ESPI´RITO SANTO DEATHS % MORTALITY RATE HOSPITALISATIONS % INCIDENCE OF HOSPITAL ADMISSION
GENDER
Male 1097 56,63 3,35 7918 53,86 50,27
Female 839 43,31 2,50 6704 45,61 41,39
AGE GROUP (YEARS)
1–19 33 1,70 0,14 774 5,27 7,87
20–49 327 16,88 1,10 4522 30,76 29,37
50 or more 1575 81,31 13,31 9326 63,44 140,85
RACE
White 639 32,99 - 5139 34,96 -
Black 203 10,48 - 1005 6,84 -
Mixed 467 24,11 - 5164 35,13 -
Asian 5 0,26 - 47 0,32 -
Indigenous 2 0,10 - 11 0,07 -
Without information 620 32,01 - 3256 22,15 -
Mortality rate and incidence of hospitalisation per 100,000 inhabitants. Source: Sistema de Informac¸ão sobre Mortalidade (SIM). Sistema de Informac¸ão Hospitalar do
Sistema U´nico de Sau´de (SIH/SUS). Data from the Department of Informatics of the Unified Health System (DATASUS - www.datasus.gov.br). Ministry of Health.
Brazil.
https://doi.org/10.1371/journal.pone.0224889.t001
Table 2. Estimates of Prais-Winsten regression analysis, related to rates of CKD, Espı´rito Santo, Brazil, from 1996 to 2017.
RATE OF STANDARDIZED CKD LINEAR REGRESSION
Β P r2 APC (CI95%)
Overall mortality 0.006 0.279 0.372 - -0.005 : 0.017
Mortality–men 0,007 0,146 0,307 - -0,003 : 0,016
Mortality–women 0,007 0,255 0,213 - -0,006 : 0,020
Mortality–women > 2005 0,033 0,013 0,083 7,870 0,009 : 0,057
1–19 -0,015 0,294 0,166 - -0,045 : 0,450
20–49 -0,020 0,007 0,290 -4,411 -0,033 : -0,006
50 years or more 0,003 0,421 0,725 - -0,005 : 0,012
Overall hospitalisation 0,026 <0,001 0,897 6,231 0,019 : 0,033
Hospitalisation–men 0,026 <0,001 0,695 6,060 0,017 : 0,034
Hospitalisation–women 0,028 <0,001 0,931 6,550 0,019 : 0,036
1–19 0,018 0,157 -0,108 - -0,009 : 0,045
20–49 0,015 0,004 0,344 3,625 0,006 : 0,025
50 years or more 0,029 <0,001 0,984 6,958 0,024 : 0,035
β–slope of the regression; r2—predictive value; CI95%—confidence interval at 95%; APC–annual percent change. Source: Sistema de Informac¸ão sobre Mortalidade
(SIM). Sistema de Informac¸ão Hospitalar do Sistema U´nico de Sau´de (SIH/SUS). Data from Department of Informatics of Unified Health System (DATASUS - www.
datasus.gov.br). Ministry of Health. Brazil.
https://doi.org/10.1371/journal.pone.0224889.t002
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Overall hospitalisation showed an increase of 6.23% per year. When stratified by gender, it
was noted an increase in both genders, which assumes values for men and women of 6.06%
and 6.60% per annum, respectively (Fig 3). Comparing hospitalisation by age group, admission
was stationary for patients aged 1 to 19 years. However, in the 20–49 and 50 or more age
groups there was an increase of 3.63% and 6.96% per annum, respectively.
In order to characterise the population, it was evidenced that more than a half of mortality
and hospitalisation correspond to the male gender, over 50 years/old. Mortality reached
32.99% in the group of white race, while in hospitalisations 35.13% corresponds to mixed race.
Discussion
In the state of Espı´rito Santo, Brazil, we found that frequency of deaths from CKD are predom-
inant in males, aged 50 and over as well as in white people. Similarly, a study conducted in 235
patients, in Peru revealed that about six in ten deaths from CKD were in men, with a mean age
of 56.4 years [20]. However, in another study with an average age of 79 (19–106), despite the
divergence of the results found for gender, they found 62% of deaths were in females. The
results for race converged, since most affected patients were of white race [21].
According to IBGE [22], Caucasians make up 52% of southeast region population and only
9% by mixed race, this population difference may explain the higher frequency of deaths and
high hospitalisation rate in the Caucasian population. A study conducted with African-Ameri-
cans showed a divergent data, observing that this population is more likely to develop kidney
disease, being associated with a higher frequency of glomerulonephritis, hypertension and dia-
betic nephropathy [23].
Fig 1. Overall mortality by CKD in Espı´rito Santo, Brazil, from 1996 to 2016. Source: author’s own elaboration, 2018.
https://doi.org/10.1371/journal.pone.0224889.g001
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Fig 2. Mortality due to chronic kidney disease stratified by gender, Espı´rito Santo, Brazil, 1996 to 2016. Source: author’s own
elaboration, 2018.
https://doi.org/10.1371/journal.pone.0224889.g002
Fig 3. Hospitalisation for CKD stratified by gender, Espı´rito Santo, Brazil, from 2008 to 2017. Source: author’s own elaboration, 2018.
https://doi.org/10.1371/journal.pone.0224889.g003
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Considering the relationship between diabetes, CKD and its rise with age, National Health
Survey showed data 0.6% between 18 and 29 years of age; 19.9% between 65 and 74 years; and
19.6% in people older than 75 years of age [12]. In addition to the relationship between diabe-
tes and CKD, it is noted that age may be the factor for the increase of CKD in our study as well
as evidenced in the scientific literature.
Regarding gender, a meta-analysis study revealed that prevalence of CKD increased with
advancing age, and two-thirds of this prevalence is in women. Prevalence has been demon-
strated to be higher in more economically developed regions, besides of increasing estimates
in developing countries and acceleration of population ageing [24]. This information con-
verges with the data found in our study, where the highest incidence of both mortality and hos-
pitalisations is related to population over 50 years.
A study in Brazil which analysed the cost of kidney disease by gender, revealed that the
highest cost was for females, where the kidney disease was associated with diabetes. A higher
prevalence of diabetes is found in females which, together with physiological factors inherent
to female gender, result in a higher relative risk in the development of chronic renal disease
and its terminal stage. It is, worth mentioning that actions are needed to strengthen the pro-
motion, prevention, surveillance and treatment of diabetes, since it is a risk factor for CKD
[25].
A systematic review and meta-analysis showed that diabetes in women boosts major
adverse effects with respect to risk factors for CKD compared to men. The research also found
a greater chance of ineffectiveness in the treatment when compared to men, since women are
more likely to develop other diseases such as hypertension, dyslipidaemia and obesity, and it is
more difficult to control glycated haemoglobin [26]. In line with this view, when mortality
with stationary behaviour was stratified by gender from 2005 onwards it was noticed an
increase of 7.87% per year in females. On the other hand, it was noted a higher incidence of
CDK among white men linked to hypertension prevalence [27].
According to Pinheiro et al. [28], compared to men, women have more access to medical
appointments, tests, and receive more medication funded by SUS. On the other hand, men
seek less health care services compared to women, mainly because of job reasons [8]. Never-
theless, in the opinion of Go´es and Nascimento [29], race is a factor that interferes with access
to health care services observing whereas 15.4% of white women have access to services, only
7.9% of black women have the same access. Despite the increased hospitalisation for both gen-
ders in the state of Espı´rito Santo, over the 10 years period (from 2008 to 2017), we noted a
lower incidence of hospitalisation in women compared to men. This can be justified by greater
access and treatment adherence for women, suggesting that female gender is more influenced
by promotion and prevention than male gender.
A Dutch study showed that during the 10 years period (from 1995 to 2005) there was an
increase in mortality rate. From a total of 13,868 patients, approximately 61% died [30]. The
rise in the death rate is often associated with old age and is due to emergency hospitalisations,
often caused by infection inherent in the vascular access or lack of arteriovenous fistula [31].
However, this study differs from previous findings, showing that mortality in Espı´rito
Santo is stationary over the same period of time (10 years). Although there is a correlation
between hospitalisation and mortality, the discrepancy between these two modalities suggests
that the health system has provided beneficial effects to this affected population, whether
through promotion, prevention and/or rehabilitation, corroborating that mortality is
stationary.
In São Paulo, Brazil, it was noted that during the first year of haemodialysis there were 112
hospitalisations, at a rate of 264/1000 patients. Of these, 47% died after hospitalisation [31].
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Meanwhile, over a period of 10 years in Espı´rito Santo, there were 14,622 hospitalisations, with
an annual increase of 6.23%.
Of the 63.3% of patients undergoing RRT in Taiwan, 33.7% died within 60 days after hospi-
tal discharge [32]. A study conducted in the administrative region of Brittany, France, showed
worse access to treatment of CKD and higher mortality among patients living in socioeconom-
ically disadvantaged areas [33]. Also, in Argentina, a close relationship was observed between
low income, low educational level and unemployment, with a higher mortality in patients on
peritoneal dialysis [34]. On the other hand, higher educational levels in developed countries
relates to lower morbidity and mortality rates of CKD and RRT [35].
Data from Brazilian Society of Nephrology (SBN) revealed the existence of 747 dialysis cen-
tres operating in Brazil. Of this total, 49% are located in the Southeast region, which in turn
includes Espı´rito Santo. Nephrology corresponds to about 1% of medical specialties, and 22%
of nephrologists are located in the Southeast region [8].
According to the Brazilian Registry of Transplant (RBT), the number of transplants per-
formed in Brazil is still far to fill country needs. In the Southeast of the country, in the period
from January to September 2018, 43 kidney transplants were performed [36]. Based on these
data from specialised services, it is suggested that the increase in transplants has promoted an
increase in hospitalisation and, thus, controlling mortality and benefiting the population.
In countries where the health system is unable to cover the cost of dialysis, prevention is a
key resource that can save lives. Thus, quality care regarding screening, diagnosis, treatment
and the cost-effectiveness of early intervention needs to be transformed into data. Health Data
is essential, it will allow corroboration with transparency about the economic consequences of
kidney disease and the need to recognize the importance of clinical guidelines [37].
In a study carried out in Beijing, the authors showed that diabetes, hypertension and heart
disease are the most common comorbidities in health care centres. However, in view of the
chronic problems, a program implementation tool was developed focusing on patients, where
a success factor has been the collaboration between doctors and patients. The management
system of these diseases is monitored in real time, with an early warning response to ensure
early diagnosis and intervention [38].
With real-time monitoring, family physicians are notified when is a delay in patient follow-
up, which ensures the ongoing management of the individual’s health. In addition, data are
generated in the system, which enables the health professionals to track the results of short-
term interventions, identify other health issues and adjust the management protocol. It was
confirmed that the application of intelligent system management of chronic diseases has pro-
vided significant improvements in the condition of patients. The authors, therefore, argue that
this should be promoted in China as well as in other developing countries [38].
Countries have begun to develop strategies for the prevention and control of non- commu-
nicable diseases due to its increasing rates of death and disability, but renal disease has low visi-
bility even being part of this group. Some countries do not particularly address renal disease,
showing a lack of awareness about other related, non-communicable diseases, such as diabetes,
hypertension and obesity, which can lead to kidney disease as a secondary outcome [39,40].
Local statistics, where available, emphasise the importance of expressing the burdens as well
as the associated financial impact of medical care and disability. In addition, for proposals for
kidney disease to be accepted, these should be articulated together with existing or planned
public health initiatives, and include other parties, such as target population that will benefit,
governments and potential allies [40].
In Brazil, the Ministry of Health finances most treatments of CKD and end stage disease.
Therefore, there is an urgent need for strategies that support the screening of kidney disease,
especially in populations of higher risks. This will help to focus public policies on reducing the
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growth of incidence of this disease, since this condition seriously impacts on the budget of
public health system [25].
Research is imperative to find new ways to achieve an optimised health system and meet
the medical needs of researchers, managers and patients. This will help to promote improve-
ments in the health system users through knowledge, new diagnosis or treatments [41]. In this
regard, evaluations of users’ satisfaction with services are common. However, it is noted that
when the evaluation is applied to service providers, it is still a sensitive topic in Brazil and in
the rest of the world [42].
It is clear that CKD is a serious public health problem that needs to be addressed and recog-
nised by health professionals so they can provide a comprehensive care to patients ranging
from prevention to rehabilitation; highlighting the importance of preventive measures and
promoting the health through referring to risk factors and also key factors related to treatment
adherence.
It is relevant the need to expand the discussion presented in this study as epidemiological
information of the state of Espı´rito Santo, so that health professionals can establish decisions
that meet the needs of the population.
It is expected that our findings may contribute to a greater visibility of the incidence of hos-
pitalisations and mortality due to CKD. Although this study represents only one Brazilian
state, it has pertinent results to incite the creation of protocols for treatment and the preven-
tion of injuries, considering the profile of this population.
Mortality studies have their own limitations when secondary data are analyzed, especially
regarding the validity of identifying the underlying cause of death. However, as was previously
mentioned, the data used in this study, even containing possible underreporting is the oficial
source from the Ministry of Health of Brazil available for decision making and formulation of
public policies. Thus, unexpected events can occur at any time, as it involves different vari-
ables, which may result in additional risk of error.
Conclusion
By analyzing the incidence of hospitalisations and mortality, we found that age and gender are
factors associated with deaths and hospitalisations for chronic kidney disease. While hospitali-
sation increases 6.23% per year, global mortality remains stationary. From 2005 onwards a
trend towards increasing of 7.87%/annual in mortality was observed in women.
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